Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing
Authors:
- Meritxell Llorens-RevullMLMeritxell Llorens-Revull
- Brenda Martínez-GonzálezBMBrenda Martínez-González
- Josep QuerJQJosep Quer
- Juan Ignacio EstebanJEJuan Ignacio Esteban
- Gonzalo Núñez-MorenoGNGonzalo Núñez-Moreno
- Pablo MínguezPablo Mínguez
- Idoia BurguiIBIdoia Burgui
- Ricardo Ramos-RuízRRRicardo Ramos-Ruíz
- María Eugenia SoriaMSMaría Eugenia Soria
- Angie RicoARAngie Rico
- Mar Riveiro-BarcielaMRMar Riveiro-Barciela
- Silvia SauledaSSSilvia Sauleda
Open Access
- 29 July 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (15) , 12183
Abstract
MicroRNAs (miRNAs) encapsulated in extracellular vesicles (EVs) are potential diagnostic and prognostic biomarkers. However, discrepancies in miRNA patterns and their validation are still frequent due to differences in sample origin, EV isolation, and miRNA sequencing methods. The aim of the present study is to find a reliable EV isolation method for miRNA sequencing, adequate for clinical application. To this aim, two comparative studies were performed in parallel with the same human plasma sample: (i) isolation and characterization of EVs obtained using three procedures: size exclusion chromatography (SEC), iodixanol gradient (GRAD), and its combination (SEC+GRAD) and (ii) evaluation of the yield of miRNA sequences obtained using NextSeq 500 (Illumina) and three miRNA library preparation protocols: NEBNext, NEXTFlex, and SMARTer smRNA-seq. The conclusion of comparison (i) is that recovery of the largest amount of EVs and reproducibility were attained with SEC, but GRAD and SEC+GRAD yielded purer EV preparations. The conclusion of (ii) is that the NEBNext library showed the highest reproducibility in the number of miRNAs recovered and the highest diversity of miRNAs. These results render the combination of GRAD EV isolation and NEBNext library preparation for miRNA retrieval as adequate for clinical applications using plasma samples.Keywords
Funding Information
- Instituto de Salud Carlos III (PI18/00210, PI19/00301, PI19/00533, PI21/00139, PI22/00258, CP14/00121, CPII19/00001, FI20/00313, IDI-20200297, SAF2014-52400-R, SAF2017-87846-R, BFU2017-91384-EXP, 525/C/2021, PID2020-113888RB-I00, PID2021-126447OB-I00, 202220I116, S2013/ABI-2906, S2018/BAA-4370, 2020/2094, PFIS FI19/00119)
- Spanish Ministry of Economy and Business (PI18/00210, PI19/00301, PI19/00533, PI21/00139, PI22/00258, CP14/00121, CPII19/00001, FI20/00313, IDI-20200297, SAF2014-52400-R, SAF2017-87846-R, BFU2017-91384-EXP, 525/C/2021, PID2020-113888RB-I00, PID2021-126447OB-I00, 202220I116, S2013/ABI-2906, S2018/BAA-4370, 2020/2094, PFIS FI19/00119)
- Ministerio de Economía y Competitividad (PI18/00210, PI19/00301, PI19/00533, PI21/00139, PI22/00258, CP14/00121, CPII19/00001, FI20/00313, IDI-20200297, SAF2014-52400-R, SAF2017-87846-R, BFU2017-91384-EXP, 525/C/2021, PID2020-113888RB-I00, PID2021-126447OB-I00, 202220I116, S2013/ABI-2906, S2018/BAA-4370, 2020/2094, PFIS FI19/00119)
- Ministerio de Ciencia, Innovación y Universidades (MCIU) (PI18/00210, PI19/00301, PI19/00533, PI21/00139, PI22/00258, CP14/00121, CPII19/00001, FI20/00313, IDI-20200297, SAF2014-52400-R, SAF2017-87846-R, BFU2017-91384-EXP, 525/C/2021, PID2020-113888RB-I00, PID2021-126447OB-I00, 202220I116, S2013/ABI-2906, S2018/BAA-4370, 2020/2094, PFIS FI19/00119)
- Fundaciό La Maratό de TV3 (PI18/00210, PI19/00301, PI19/00533, PI21/00139, PI22/00258, CP14/00121, CPII19/00001, FI20/00313, IDI-20200297, SAF2014-52400-R, SAF2017-87846-R, BFU2017-91384-EXP, 525/C/2021, PID2020-113888RB-I00, PID2021-126447OB-I00, 202220I116, S2013/ABI-2906, S2018/BAA-4370, 2020/2094, PFIS FI19/00119)
- Ministerio de Ciencia e Innovaciόn (MICINN) (PI18/00210, PI19/00301, PI19/00533, PI21/00139, PI22/00258, CP14/00121, CPII19/00001, FI20/00313, IDI-20200297, SAF2014-52400-R, SAF2017-87846-R, BFU2017-91384-EXP, 525/C/2021, PID2020-113888RB-I00, PID2021-126447OB-I00, 202220I116, S2013/ABI-2906, S2018/BAA-4370, 2020/2094, PFIS FI19/00119)
- Comunidad de Madrid/FEDER (PI18/00210, PI19/00301, PI19/00533, PI21/00139, PI22/00258, CP14/00121, CPII19/00001, FI20/00313, IDI-20200297, SAF2014-52400-R, SAF2017-87846-R, BFU2017-91384-EXP, 525/C/2021, PID2020-113888RB-I00, PID2021-126447OB-I00, 202220I116, S2013/ABI-2906, S2018/BAA-4370, 2020/2094, PFIS FI19/00119)
- European Commission–NextGenerationEU (PI18/00210, PI19/00301, PI19/00533, PI21/00139, PI22/00258, CP14/00121, CPII19/00001, FI20/00313, IDI-20200297, SAF2014-52400-R, SAF2017-87846-R, BFU2017-91384-EXP, 525/C/2021, PID2020-113888RB-I00, PID2021-126447OB-I00, 202220I116, S2013/ABI-2906, S2018/BAA-4370, 2020/2094, PFIS FI19/00119)
- ISCIII (PI18/00210, PI19/00301, PI19/00533, PI21/00139, PI22/00258, CP14/00121, CPII19/00001, FI20/00313, IDI-20200297, SAF2014-52400-R, SAF2017-87846-R, BFU2017-91384-EXP, 525/C/2021, PID2020-113888RB-I00, PID2021-126447OB-I00, 202220I116, S2013/ABI-2906, S2018/BAA-4370, 2020/2094, PFIS FI19/00119)
- Fundación Ramón Areces (PI18/00210, PI19/00301, PI19/00533, PI21/00139, PI22/00258, CP14/00121, CPII19/00001, FI20/00313, IDI-20200297, SAF2014-52400-R, SAF2017-87846-R, BFU2017-91384-EXP, 525/C/2021, PID2020-113888RB-I00, PID2021-126447OB-I00, 202220I116, S2013/ABI-2906, S2018/BAA-4370, 2020/2094, PFIS FI19/00119)
- Banco Santander (PI18/00210, PI19/00301, PI19/00533, PI21/00139, PI22/00258, CP14/00121, CPII19/00001, FI20/00313, IDI-20200297, SAF2014-52400-R, SAF2017-87846-R, BFU2017-91384-EXP, 525/C/2021, PID2020-113888RB-I00, PID2021-126447OB-I00, 202220I116, S2013/ABI-2906, S2018/BAA-4370, 2020/2094, PFIS FI19/00119)
This publication has 49 references indexed in Scilit:
- Characterization of human plasma-derived exosomal RNAs by deep sequencingBMC Genomics, 2013
- Standardization of sample collection, isolation and analysis methods in extracellular vesicle researchJournal of Extracellular Vesicles, 2013
- The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in ExosomesPLOS ONE, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteinsNature Cell Biology, 2011
- Gene silencing by microRNAs: contributions of translational repression and mRNA decayNature Reviews Genetics, 2011
- Exosomes – vesicular carriers for intercellular communicationCurrent Opinion in Cell Biology, 2009
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature Cell Biology, 2008
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences, 2008
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007